You have 9 free searches left this month | for more free features.

TKI

Showing 1176 - 1196 of 1,196

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Adenocarcinoma Trial in Goyang-si (Gefitinib, Placebo, Pemetrexed plusCIsplatin)

Unknown status
  • Non Small Cell Lung Cancer
  • Adenocarcinoma
  • Goyang-si, Gyenggido, Korea, Republic of
    National Cancer Center
Jun 19, 2012

NSCLC Trial in Boston (Cetuximab)

Terminated
  • Non-small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Aug 2, 2012

Lung Cancer Trial in United States (pemetrexed)

Terminated
  • Lung Cancer
  • Anchorage, Alaska
  • +111 more
Oct 3, 2012

Breast Cancer Trial (gefitinib)

Unknown status
  • Breast Cancer
  • (no location specified)
Nov 30, 2012

Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in Houston (Interleukin-11 (IL-11 or Neumega))

Completed
  • Leukemia
  • +2 more
  • Interleukin-11 (IL-11 or Neumega)
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 17, 2012

Lung Cancer, NSCLC Trial in Goyang-si (Erlotinib, Induction or consolidation IP chemo, CCRT with IP chemo (Irinotecan +

Unknown status
  • Lung Cancer
  • NSCLC
  • Goyang-si, Gyenggi-do, Korea, Republic of
    National Cancer Center, Korea
Nov 4, 2011

Tumors, Cancer, Tumors Trial in Glasgow, Sutton (CHIR-258 (TKI258))

Terminated
  • Neoplasms
  • +2 more
  • CHIR-258 (TKI258)
  • Glasgow, United Kingdom
  • +1 more
Jan 4, 2011

The Roles of Neutrophil Elastase in Lung Cancer

Unknown status
  • Lung Cancer
  • Chronic Obstructive Pulmonary Diseases
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    May 27, 2011

    Squamous Cell Carcinoma of Bronchus Trial in Seoul (Gefitinib)

    Unknown status
    • Squamous Cell Carcinoma of Bronchus
    • Seoul, Korea, Republic of
      Seoul Veterans Hospital
    Dec 5, 2011

    Acute Myeloid Leukemia Trial in Houston (TKI258)

    Terminated
    • Acute Myeloid Leukemia
    • Houston, Texas
      The University of Texas, M.D. Anderson Cancer Center
    Jun 29, 2010

    NSCLC Trial in Hangzhou (Prophylactic cranial irradiation, Erlotinib /Gefitinib)

    Unknown status
    • Non-small Cell Lung Cancer
    • Prophylactic cranial irradiation
    • Erlotinib /Gefitinib
    • Hangzhou, Zhejiang, China
    • +1 more
    Jul 6, 2010

    NSCLC, Adenocarcinoma, Bronchiolo-Alveolar Trial in Seattle (VELCADE)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Adenocarcinoma, Bronchiolo-Alveolar
    • Seattle, Washington
      Swedish Cancer Institute
    Feb 16, 2011

    Esophageal Cancer Trial in Hangzhou (gefitinib, Thoracic radiotherapy)

    Unknown status
    • Esophageal Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Feb 7, 2011

    Multiple Myeloma Trial in United States (TKI258)

    Terminated
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +4 more
    Nov 20, 2009

    NSCLC Trial in Hangzhou (Erlotinib, Thoracic radiotherapy)

    Unknown status
    • Non-small Cell Lung Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    May 13, 2010

    Non-Small-Cell Lung Cancer Trial in Taipei City (UFUR and Iressa)

    Completed
    • Non-Small-Cell Lung Cancer
    • UFUR and Iressa
    • Taipei City, Taiwan
      Taipei VGH
    Dec 22, 2009

    NSCLC Trial in Taipei (cancer cell lines establishment)

    Unknown status
    • NSCLC
    • cancer cell lines establishment
    • Taipei, Taiwan
    • +1 more
    Nov 25, 2009

    NSCLC Trial in Worldwide (BMS-275183 (oral taxane))

    Terminated
    • Non-small Cell Lung Cancer
    • BMS-275183 (oral taxane)
    • Burlington, Massachusetts
    • +29 more
    Feb 27, 2010

    Non Small Cell Lung Cancer Trial in Athens, Thessaloniki (Erlotinib)

    Completed
    • Non Small Cell Lung Cancer
    • Athens, Greece
    • +4 more
    Dec 14, 2009

    NSCLC Trial in Tainan (erlotinib (Tarceva), pemetrexed (Alimta))

    Unknown status
    • Non-Small Cell Lung Cancer
    • erlotinib (Tarceva)
    • pemetrexed (Alimta)
    • Tainan, Taiwan
      National Cheng-Kung University Hospital
    May 15, 2009

    NSCLC, Brain Metastasis Trial (gefitinib)

    Unknown status
    • Non-Small Cell Lung Cancer
    • Brain Metastasis
    • (no location specified)
    Feb 13, 2008